Keyphrases
Pancreatic Ductal Adenocarcinoma
100%
Chemoresistance
44%
Post-transplant Lymphoproliferative Disorder
44%
Tumor
43%
Pancreatic Cancer
36%
CCR2
29%
Pathway Inhibitors
29%
Poor Prognosis
29%
Pancreatic Duct Cells
26%
Clinical Outcomes
25%
MYC Protein
24%
DUSP6
23%
Epstein-Barr Virus
22%
Hepatocellular Carcinoma
22%
Interleukin-1β
22%
Myeloproliferative Neoplasms
21%
Colorectal Cancer
20%
Id Proteins
19%
Gemcitabine
19%
NF-B
18%
T Cells
18%
Tumorigenesis
17%
Oncogene
17%
Tumor Cells
17%
Immunophenotypic Profile
16%
Tumor Fibrosis
16%
Acute Myeloid Leukemia
16%
C-Myc
16%
Leukemic Progression
14%
Epithelial Cell Adhesion Molecule (EpCAM)
14%
IRAK4
14%
Chemokine Receptor 2
14%
Induced Senescence
14%
Liver Pathology
14%
Distant Metastasis
14%
Positron Emission Tomography-computed Tomography (PET-CT)
14%
Pembrolizumab
14%
Late Response
14%
Prognosis Prediction
14%
Clonal Identity
14%
Stem Cell Markers
14%
Pseudoprogression
14%
Content-aware
14%
Pevonedistat
14%
JAK2 Inhibitor
14%
Hematopathology
14%
Smear Slide
14%
Bone Marrow Aspirate Smears
14%
SRY-box Transcription Factor 9 (SOX9)
14%
Magnetic Resonance
14%
Medicine and Dentistry
Pancreas Adenocarcinoma
88%
Neoplasm
58%
Pancreas Cancer
44%
Drive
44%
Hepatocellular Carcinoma
29%
Chemokine Receptor
29%
Myeloproliferative Neoplasm
29%
Posttransplant Lymphoproliferative Disease
29%
Diseases
26%
Epstein Barr Virus
20%
Cell Marker
19%
Biopsy Technique
19%
Stem Cell
19%
Secondary Acute Myeloid Leukemia
19%
Mass Cytometry
16%
Gemcitabine
16%
Positron Emission Tomography
16%
Tumor Cell
16%
Fibrosis
15%
Drug Conjugate
14%
Epithelial Cell Adhesion Molecule
14%
Beta Chemokine
14%
Liver Pathology
14%
Pembrolizumab
14%
Positron Emission Tomography-Computed Tomography
14%
Acute B-Cell Lymphoblastic Leukemia
14%
Distant Metastasis
14%
Pevonedistat
14%
Epidermal Growth Factor Receptor 2
14%
Hematopathology
14%
Gamma Urogastrone
14%
Mitogen-Activated Protein Kinase
14%
Multiple Myeloma
14%
Colorectal Carcinoma
14%
Drug Resistance
14%
Telomerase Reverse Transcriptase
14%
B-Cell Lymphoma
14%
Foregut
14%
Lung Transplantation
14%
In Vitro
14%
Janus Kinase
14%
Acute Graft Versus Host Disease
14%
Immunotherapy
14%
Copper Nanoparticle
14%
Interleukin 1 Receptor Associated Kinase 4
14%
Gastrointestinal Disease
14%
Intestine Perforation
14%
Lymphoma Cell
14%
NK T Cell Lymphoma
14%
Skin Nodule
14%
Biochemistry, Genetics and Molecular Biology
Drive
44%
Drug Resistance
44%
Carcinogenesis
32%
KRAS
29%
Inhibitor of Differentiation Protein
29%
Myeloid
27%
Kinase
22%
Phosphotransferase
22%
Mouse Model
22%
Mitogen-Activated Protein Kinase
17%
Oncogene
17%
B Cell
15%
Janus Kinase
14%
Epidermal Growth Factor Receptor
14%
Mass Cytometry
14%
Conjugate
14%
Stem Cell Marker
14%
Interleukin-1 Receptor-Associated Kinase
14%
IRAK4
14%
Isoform
14%
DUSP6
14%
Epithelial Cell Adhesion Molecule
14%
SOX9
14%
Host
14%
Telomerase Reverse Transcriptase
14%
Cell Cycle
14%
Transcription Factor NFAT
14%
Angiogenesis
14%
Heat Shock Protein
14%
Antiangiogenic Activity
14%
Oncogene Neu
14%
Hsp90
14%
Endothelial Progenitor Cell
14%
Myc
14%
Nuclear Transport
14%
Missense Mutation
14%
Wild Type
14%
Transcription Factors
12%
Fibroblast
12%
Messenger RNA
9%
RNA
9%
Hematopoietic Cell
9%
Tumor Progression
9%
Dual-Specificity Phosphatase
8%
Programmed Cell Death
7%
Prevalence
7%
Fibroblast Growth Factor Receptor 1
7%
Vascularization
7%
Genetic Model
7%
Mouse Mutant
7%